Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sean F. Scanlan Insider Profile
4 Followers
Sean F. Scanlan, Chief Innovation Officer at Treace Medical Concepts, holds 95.42K shares in Treace Medical Concepts (Ticker: TMCI).
Sean F. Scanlan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Sean F. Scanlan's holdings
Insider Roles
Chief Innovation Officer
Roles that Sean F. Scanlan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 10, 2023 - Mar 10, 2024
Return:+45.40%
The most profitable trade made by Sean F. Scanlan
Sean F. Scanlan's Trading History
List of latest transactions for each holding click on a transaction to see Sean F. Scanlan's performance on stock
You May Also Like
Sean F. Scanlan insider profile FAQ
What is the percentage of profitable transactions made by Sean F. Scanlan?
The percentage of profitable transactions made by Sean F. Scanlan is ―.
What is the average return per transaction made by Sean F. Scanlan?
The average return per transaction made by Sean F. Scanlan is ―.
What stocks does Sean F. Scanlan hold?
Sean F. Scanlan holds: TMCI stocks.
What was Sean F. Scanlan’s latest transaction?
Sean F. Scanlan latest transaction was an Uninformative Sell of ―.
What was Sean F. Scanlan's most profitable transaction?
Sean F. Scanlan’s most profitable transaction was an Informative Sell of TMCI stock on March 10, 2023. The return on the trade was 45.40%.
What is Sean F. Scanlan's role in Treace Medical Concepts?
Sean F. Scanlan's role in Treace Medical Concepts is Chief Innovation Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.